We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-0.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$280M
AUM Growth
-$12.6M
Cap. Flow
-$11.9M
Cap. Flow %
-4.24%
Top 10 Hldgs %
55.57%
Holding
53
New
13
Increased
14
Reduced
5
Closed
20

Top Buys

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$14.5M
2
ENR icon
Energizer
ENR
+$11.5M
3
HAIN icon
Hain Celestial
HAIN
+$10.2M
4
VNDA icon
Vanda Pharmaceuticals
VNDA
+$8.68M
5
THC icon
Tenet Healthcare
THC
+$8.27M

Top Sells

Rank Stock Value
1
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$15.2M
2
XNPT
XENOPORT, INC.
XNPT
+$12.6M
3
KODK icon
Kodak
KODK
+$12.6M
4
BDBD
BOULDER BRANDS INC
BDBD
+$10.4M
5
PBY
PEP BOYS MANNY MOE& JACK
PBY
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 45.72%
2 Consumer Discretionary 14.08%
3 Consumer Staples 8.36%
4 Industrials 6.68%
5 Financials 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TENX icon
26
Tenax Therapeutics
TENX
$402M
$3.25M 1.16%
31
+28
+933% +$2.9M
TUMI
27
DELISTED
TUMI HLDGS INC COM
TUMI
$3.13M 1.12%
+188,000
New +$3.21M
ILG
28
DELISTED
ILG, Inc Common Stock
ILG
$2.65M 0.95%
+170,000
New +$2.89M
BKS
29
DELISTED
Barnes & Noble
BKS
$1.74M 0.62%
+200,000
New +$2.35M
XYLO
30
DELISTED
Xylo Technologies
XYLO
$1.64M 0.58%
381
+5
+1% +$28.6K
RLOC
31
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$1.51M 0.54%
918,000
+614,000
+202% +$798K
ANF icon
32
Abercrombie & Fitch
ANF
$4.52B
– –
-240,000
Closed -$5.09M
ARMP icon
33
Armata Pharmaceuticals
ARMP
$176M
– –
-670
Closed -$371K
BBBY
34
Bed Bath & Beyond
BBBY
$479M
– –
-239,580
Closed -$3.09M
GSK icon
35
CALL
GSK
GSK
$106B
– –
-320,000
Closed -$15.4M
KODK icon
36
Kodak
KODK
$814M
– –
-804,000
Closed -$12.6M
LVS icon
37
Las Vegas Sands
LVS
$32B
– –
-190,000
Closed -$7.21M
MDGL icon
38
Madrigal Pharmaceuticals
MDGL
$12.4B
– –
-57,143
Closed -$3.48M
NSPR icon
39
InspireMD
NSPR
$31.6M
– –
-1
Closed -$1.07M
VNCE icon
40
Vince Holding Corp
VNCE
$79M
– –
-154,000
Closed -$5.28M
CBAY
41
DELISTED
Cymabay Therapeutics
CBAY
– –
-836,000
Closed -$1.62M
FPRX
42
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-506,000
Closed -$7.79M
DFRG
43
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
– –
-422,000
Closed -$5.86M
FTD
44
DELISTED
FTD Companies, Inc. Common Stock
FTD
– –
-186,000
Closed -$5.54M
APOL
45
DELISTED
Apollo Education Group Inc Class A
APOL
– –
-880,000
Closed -$9.73M
CPHR
46
DELISTED
Cipher Pharmaceuticals Inc.
CPHR
– –
-300,000
Closed -$1.11M
PTX
47
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-480,000
Closed -$15.2M
SKUL
48
DELISTED
SKULLCANDY INC
SKUL
– –
-854,000
Closed -$4.72M
GMCR
49
DELISTED
KEURIG GREEN MTN INC
GMCR
– –
-154,000
Closed -$8.03M
PBY
50
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
– –
-840,000
Closed -$10.2M
1
2
3

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Armistice Capital's Q4 2015 Portfolio in Review

As of Q4 2015, Armistice Capital held 53 positions worth $280M, down 4.3% from $293M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $11.9M in Q4 2015, closing 20 positions and reducing 5 holdings. Its most notable exit was Pernix Therapeutics Holdings, Inc., an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Aegerion Pharmaceuticals worth $12.1M.

  • Armistice Capital's largest Q4 2015 buy was Aegerion Pharmaceuticals: 1,202,000 shares worth $12.1M.
  • Armistice Capital added most to Vanda Pharmaceuticals in Q4 2015, an estimated $8.68M increase.
  • Armistice Capital's biggest Q4 2015 reduction was XENOPORT, INC., cutting an estimated $12.6M.
  • Armistice Capital fully exited Pernix Therapeutics Holdings, Inc. in Q4 2015, selling an estimated $15.2M.
  • Armistice Capital's ten largest holdings make up 56% of its $280M portfolio in Q4 2015.
  • Armistice Capital opened 13 new positions and closed 20 in Q4 2015.
  • Armistice Capital's portfolio value fell 4.3% quarter-over-quarter to $280M.

Based on Armistice Capital's 13F filing for Q4 2015, filed 16 Feb 2016.